Profile
Sean Davis currently works at SEVER Life Sciences BV, as Chief Executive Officer and Ferring Pharmaceuticals Ltd., as General Manager.
Sean Davis active positions
Companies | Position | Start |
---|---|---|
Ferring Pharmaceuticals Ltd.
Ferring Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals Ltd. manufactures and produces pharmaceutical products. It offers Zomacton (somatropin) for that treatment of growth failure in children and for girl’s diagnosed with Turners syndrome; GONAPEPTYL (triptorelin), a GnRH agonist that is used for the treatment of children with central precocious puberty; Testim (testosterone gel), a hydroalcoholic topical gel; and PENTASA (mesalazine), which is used for the treatment of inflammatory bowel diseases. The company was founded in 1975 and is headquartered in Middlesex, the United Kingdom. | Chief Executive Officer | - |
SEVER Life Sciences BV | Chief Executive Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Ferring Pharmaceuticals Ltd.
Ferring Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals Ltd. manufactures and produces pharmaceutical products. It offers Zomacton (somatropin) for that treatment of growth failure in children and for girl’s diagnosed with Turners syndrome; GONAPEPTYL (triptorelin), a GnRH agonist that is used for the treatment of children with central precocious puberty; Testim (testosterone gel), a hydroalcoholic topical gel; and PENTASA (mesalazine), which is used for the treatment of inflammatory bowel diseases. The company was founded in 1975 and is headquartered in Middlesex, the United Kingdom. | Health Technology |
SEVER Life Sciences BV |
- Stock Market
- Insiders
- Sean Davis